Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Semin Dial. 2022 May;35(3):228-235. doi: 10.1111/sdi.13036. Epub 2021 Nov 4.
It is necessary to assess the association between the preoperative indicators and the maturation and survival of arteriovenous fistula (AVF).
We retrospectively identified 236 patients with a new AVF created between 2016 and 2018 in our Dialysis Center.
Multivariate Logistic regression showed that preoperative arterial diameter (odds ratio [OR] = 1.452, 95% confidence interval [CI] [1.233, 1.710], p < 0.001), preoperative venous diameter (OR = 1.296, 95% CI [1.166, 1.477], p < 0.001), left ventricular ejection fraction (LVEF) (OR = 1.187, 95% CI [1.103, 1.277], p < 0.001), and diabetes mellitus (OR = 0.245, 95% CI [0.107, 0.560], p = 0.01) were independent influential factors for AVF maturation. Two years after the AVF surgery follow-up, multivariate Cox proportional-hazards model showed that the preoperative arterial diameter (OR = 0.510, 95% CI [0.320, 0.813], p = 0.005), preoperative venous diameter (OR = 0.940, 95% CI [0.897, 0.985], p = 0.010) and diabetes mellitus (OR = 1.785, 95% CI [1.117, 2.855], p = 0.016) was prognostic factors of AVF survival. The Kaplan-Meier method showed that the primary survival of AVF in patients with different preoperative arterial diameter was statistically significant (log-rank χ = 15.415, p < 0.001), while the secondary survival was not statistically significant (log-rank χ = 0.131, p = 0.717).
In our cohort, the preoperative arterial and venous diameter and diabetes mellitus were independent influential factors for AVF maturation and prognostic factors of AVF survival. However, the preoperative LVEF only associated with the maturation of AVF. Meanwhile, smaller arterial diameter (≤2.15 mm) was associated with AVF maturation failure, but did not impact secondary survival of AVF.
有必要评估术前指标与动静脉瘘(AVF)成熟和存活之间的关系。
我们回顾性地确定了 2016 年至 2018 年期间在我们的透析中心创建的 236 例新的 AVF 患者。
多变量 Logistic 回归显示,术前动脉直径(优势比 [OR] = 1.452,95%置信区间 [CI] [1.233, 1.710],p < 0.001)、术前静脉直径(OR = 1.296,95% CI [1.166, 1.477],p < 0.001)、左心室射血分数(LVEF)(OR = 1.187,95% CI [1.103, 1.277],p < 0.001)和糖尿病(OR = 0.245,95% CI [0.107, 0.560],p = 0.01)是 AVF 成熟的独立影响因素。AVF 手术后 2 年随访的多变量 Cox 比例风险模型显示,术前动脉直径(OR = 0.510,95% CI [0.320, 0.813],p = 0.005)、术前静脉直径(OR = 0.940,95% CI [0.897, 0.985],p = 0.010)和糖尿病(OR = 1.785,95% CI [1.117, 2.855],p = 0.016)是 AVF 存活的预后因素。Kaplan-Meier 法显示,不同术前动脉直径患者的 AVF 主要存活率具有统计学意义(对数秩 χ ²= 15.415,p < 0.001),而次要存活率无统计学意义(对数秩 χ ²= 0.131,p = 0.717)。
在我们的队列中,术前动脉和静脉直径以及糖尿病是 AVF 成熟和 AVF 存活的预后因素的独立影响因素。然而,术前 LVEF 仅与 AVF 的成熟有关。同时,较小的动脉直径(≤2.15mm)与 AVF 成熟失败相关,但不影响 AVF 的次要存活。